| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
30,325 |
24,356 |
$2.54M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
20,323 |
17,207 |
$1.52M |
| 99442 |
|
11,845 |
11,282 |
$993K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,100 |
8,233 |
$991K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12,065 |
10,734 |
$864K |
| 36415 |
Collection of venous blood by venipuncture |
72,621 |
20,446 |
$697K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
11,918 |
9,000 |
$542K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
20,119 |
17,750 |
$318K |
| 99201 |
|
3,955 |
3,846 |
$302K |
| 99441 |
|
4,696 |
4,468 |
$296K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,686 |
2,384 |
$264K |
| 99443 |
|
2,493 |
2,422 |
$258K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
5,328 |
3,824 |
$240K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,536 |
2,276 |
$238K |
| D0999 |
Unspecified diagnostic procedure, by report |
1,344 |
1,120 |
$215K |
| 99215 |
Prolong outpt/office vis |
1,770 |
1,469 |
$213K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
6,447 |
6,228 |
$204K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
10,717 |
10,483 |
$189K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
6,278 |
6,122 |
$186K |
| 86769 |
|
6,779 |
6,326 |
$178K |
| 90750 |
|
1,056 |
1,051 |
$177K |
| D9999 |
Unspecified adjunctive procedure, by report |
1,204 |
1,110 |
$171K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,452 |
1,419 |
$167K |
| 86480 |
|
2,255 |
2,210 |
$138K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,136 |
1,119 |
$138K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
723 |
706 |
$120K |
| 80061 |
Lipid panel |
10,403 |
10,243 |
$114K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,053 |
1,051 |
$113K |
| 90677 |
|
545 |
541 |
$105K |
| 90651 |
|
1,058 |
1,050 |
$98K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,336 |
3,303 |
$94K |
| 86703 |
|
6,822 |
6,607 |
$94K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,366 |
2,327 |
$86K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
11,406 |
11,115 |
$85K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
673 |
669 |
$78K |
| 90686 |
|
4,529 |
4,497 |
$72K |
| 92551 |
|
1,285 |
293 |
$69K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,437 |
5,326 |
$69K |
| 86780 |
|
5,103 |
4,996 |
$63K |
| 80053 |
Comprehensive metabolic panel |
5,329 |
5,226 |
$62K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,595 |
5,955 |
$62K |
| 85027 |
|
12,427 |
12,177 |
$62K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,017 |
2,983 |
$54K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,223 |
2,033 |
$47K |
| 90715 |
|
1,615 |
1,605 |
$47K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
570 |
548 |
$46K |
| 0012A |
|
1,101 |
1,088 |
$43K |
| 80076 |
|
5,121 |
5,031 |
$42K |
| 86803 |
|
3,548 |
3,497 |
$42K |
| 90461 |
|
820 |
806 |
$40K |
| 0011A |
|
1,189 |
1,185 |
$38K |
| 96116 |
|
296 |
277 |
$37K |
| 96127 |
|
6,134 |
5,818 |
$36K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
256 |
256 |
$35K |
| 90746 |
|
526 |
525 |
$31K |
| 90620 |
|
387 |
384 |
$30K |
| 96112 |
|
309 |
279 |
$28K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
816 |
802 |
$27K |
| 81001 |
|
6,900 |
6,227 |
$25K |
| 97802 |
|
867 |
797 |
$24K |
| 82728 |
|
1,924 |
1,885 |
$23K |
| 82607 |
|
1,646 |
1,618 |
$21K |
| D1110 |
Prophylaxis - adult |
1,080 |
1,077 |
$21K |
| 99051 |
|
938 |
906 |
$20K |
| 3074F |
|
8,052 |
6,853 |
$20K |
| 83655 |
|
1,249 |
1,228 |
$16K |
| 87340 |
|
1,685 |
1,629 |
$16K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
524 |
515 |
$15K |
| 92250 |
|
322 |
319 |
$14K |
| 90732 |
|
135 |
135 |
$14K |
| 86706 |
|
1,343 |
1,312 |
$13K |
| D0274 |
Bitewings - four radiographic images |
1,227 |
1,222 |
$13K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
131 |
128 |
$12K |
| 91322 |
|
142 |
136 |
$12K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
527 |
437 |
$12K |
| 90480 |
|
260 |
260 |
$11K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
614 |
543 |
$11K |
| 83550 |
|
1,611 |
1,572 |
$11K |
| 82043 |
|
2,083 |
2,052 |
$11K |
| 99401 |
|
319 |
131 |
$11K |
| 84153 |
|
661 |
654 |
$10K |
| D0150 |
Comprehensive oral evaluation - new or established patient |
905 |
848 |
$10K |
| 83540 |
|
1,830 |
1,789 |
$10K |
| 81025 |
|
1,658 |
1,582 |
$9K |
| 82274 |
|
793 |
788 |
$9K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
246 |
171 |
$8K |
| D0220 |
Intraoral - periapical first radiographic image |
1,661 |
1,651 |
$8K |
| 99385 |
|
62 |
62 |
$8K |
| 84439 |
|
992 |
983 |
$8K |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
384 |
205 |
$8K |
| 86765 |
|
631 |
607 |
$8K |
| 86762 |
|
557 |
540 |
$8K |
| 88142 |
|
339 |
311 |
$7K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
1,780 |
1,598 |
$7K |
| 97803 |
|
336 |
333 |
$7K |
| 86704 |
|
641 |
629 |
$7K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
774 |
768 |
$6K |
| 82652 |
|
123 |
118 |
$6K |
| G0511 |
Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month |
119 |
99 |
$6K |
| T2022 |
Case management, per month |
97 |
69 |
$5K |
| 90656 |
|
374 |
374 |
$5K |
| 86735 |
|
508 |
493 |
$5K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
16 |
16 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
726 |
699 |
$5K |
| 86787 |
|
487 |
469 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
327 |
221 |
$5K |
| 84703 |
|
264 |
172 |
$4K |
| 83020 |
|
245 |
238 |
$4K |
| D0120 |
Periodic oral evaluation - established patient |
384 |
379 |
$4K |
| 90734 |
|
209 |
207 |
$4K |
| 90662 |
|
135 |
135 |
$3K |
| D0230 |
Intraoral - periapical each additional radiographic image |
907 |
900 |
$3K |
| 82746 |
|
221 |
216 |
$3K |
| 81003 |
|
1,112 |
895 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
62 |
61 |
$2K |
| 84702 |
|
173 |
169 |
$2K |
| D0330 |
Panoramic radiographic image |
354 |
354 |
$2K |
| 87800 |
|
69 |
68 |
$2K |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
13 |
13 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
14 |
14 |
$2K |
| D0210 |
Intraoral - complete series of radiographic images |
151 |
151 |
$2K |
| 99384 |
|
12 |
12 |
$2K |
| 90670 |
|
26 |
26 |
$2K |
| 99205 |
Prolong outpt/office vis |
13 |
13 |
$2K |
| D7140 |
Extraction, erupted tooth or exposed root |
53 |
26 |
$1K |
| 90653 |
|
52 |
52 |
$1K |
| 99383 |
|
12 |
12 |
$1K |
| 90694 |
|
38 |
38 |
$1K |
| 86140 |
|
298 |
288 |
$1K |
| D1206 |
Topical application of fluoride varnish |
85 |
85 |
$1K |
| 99381 |
|
58 |
57 |
$1K |
| 85651 |
|
260 |
252 |
$790.41 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
26 |
25 |
$764.32 |
| D1120 |
Prophylaxis - child |
40 |
40 |
$726.79 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
13 |
12 |
$686.00 |
| 86696 |
|
31 |
29 |
$520.46 |
| 0124A |
|
12 |
12 |
$502.10 |
| 90633 |
|
43 |
43 |
$463.27 |
| 87486 |
|
16 |
16 |
$428.82 |
| 87581 |
|
16 |
16 |
$390.52 |
| 86695 |
|
31 |
29 |
$386.15 |
| 82550 |
|
80 |
78 |
$376.41 |
| 82947 |
|
83 |
80 |
$376.14 |
| 99188 |
|
14 |
14 |
$339.57 |
| 83001 |
|
12 |
12 |
$235.98 |
| 86580 |
|
25 |
25 |
$232.14 |
| 83921 |
|
12 |
12 |
$226.94 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
314 |
294 |
$225.42 |
| 91319 |
|
20 |
15 |
$210.21 |
| 82465 |
|
63 |
63 |
$198.55 |
| 83090 |
|
12 |
12 |
$191.73 |
| 87081 |
|
26 |
25 |
$188.54 |
| 90710 |
|
12 |
12 |
$175.70 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
78 |
75 |
$174.78 |
| Q3014 |
Telehealth originating site facility fee |
15 |
12 |
$156.51 |
| 86592 |
|
51 |
51 |
$139.23 |
| 85045 |
|
40 |
39 |
$135.47 |
| 96161 |
|
29 |
29 |
$113.58 |
| 86708 |
|
12 |
12 |
$99.85 |
| D0140 |
Limited oral evaluation - problem focused |
14 |
14 |
$60.10 |
| 3078F |
|
7,013 |
6,526 |
$0.00 |
| 99499 |
|
496 |
375 |
$0.00 |
| 3077F |
|
1,428 |
1,347 |
$0.00 |
| 1160F |
|
374 |
339 |
$0.00 |
| 1159F |
|
533 |
443 |
$0.00 |
| G0466 |
Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
53 |
51 |
$0.00 |
| 99080 |
|
25 |
21 |
$0.00 |
| 90658 |
|
30 |
29 |
$0.00 |
| 3075F |
|
1,944 |
1,881 |
$0.00 |
| 3079F |
|
2,939 |
2,778 |
$0.00 |
| 3080F |
|
423 |
399 |
$0.00 |
| D1330 |
|
197 |
197 |
$0.00 |
| S9451 |
Exercise classes, non-physician provider, per session |
99 |
99 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
163 |
163 |
$0.00 |
| 1220F |
|
109 |
109 |
$0.00 |
| D1208 |
Topical application of fluoride, excluding varnish |
13 |
13 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
28 |
28 |
$0.00 |